When health officials set up a monkeypox vaccination clinic at a major LGBTQIA+ festival in Louisiana, they wanted to know who was showing up for the shot. This report describes the characteristics of the people who received the JYNNEOS vaccine before and during the festival. It's important to note that this is not a clinical trial. The report doesn't tell us how well the vaccine worked at preventing infection, what side effects people experienced, or how many people were vaccinated. It simply gives a snapshot of who was getting vaccinated in that specific place and time. Without details on the number of people or their specific outcomes, this information is best seen as a starting point for understanding vaccination efforts in community settings.
Who got the monkeypox vaccine at a major LGBTQIA+ festival in Louisiana?
Photo by Dmytro Vynohradov / Unsplash
What this means for you:
A report describes who got the monkeypox vaccine at a Louisiana festival, but doesn't measure its effects. More on Mpox
Technical report validates AI tool for classifying MPXV subclades using genomic data New AI tool quickly identifies dangerous mpox virus types from DNA samples
medRxiv · Apr 28, 2026
Review of genomic surveillance finds concurrent Mpox subclade circulation across Africa Mpox Is Spreading in Ways Scientists Didn't See Coming
medRxiv · Apr 18, 2026
Observational analysis examines mpox cases in New York City New York City health officials analyze mpox case data to track the outbreak
CDC · Apr 5, 2026
Survey explores possible undetected mpox infection among people experiencing homelessness in San Francisco Did mpox spread undetected among people experiencing homelessness?
CDC · Apr 5, 2026